- Home
- STRO vs CARE Comparison
STRO vs CARE Comparison
Compare STRO & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- CARE
- Stock Information
- Founded
- STRO 2003
- CARE 1974
- Country
- STRO United States
- CARE United States
- Employees
- STRO N/A
- CARE N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- CARE Major Banks
- Sector
- STRO Health Care
- CARE Finance
- Exchange
- STRO Nasdaq
- CARE Nasdaq
- Market Cap
- STRO 172.8M
- CARE 400.8M
- IPO Year
- STRO 2018
- CARE N/A
- Fundamental
- Price
- STRO $1.72
- CARE $17.03
- Analyst Decision
- STRO Strong Buy
- CARE Buy
- Analyst Count
- STRO 7
- CARE 2
- Target Price
- STRO $12.14
- CARE $21.50
- AVG Volume (30 Days)
- STRO 1.1M
- CARE 71.5K
- Earning Date
- STRO 11-13-2024
- CARE 01-23-2025
- Dividend Yield
- STRO N/A
- CARE N/A
- EPS Growth
- STRO N/A
- CARE N/A
- EPS
- STRO N/A
- CARE 0.62
- Revenue
- STRO $160,955,000.00
- CARE $128,505,000.00
- Revenue This Year
- STRO N/A
- CARE N/A
- Revenue Next Year
- STRO N/A
- CARE $19.45
- P/E Ratio
- STRO N/A
- CARE $26.76
- Revenue Growth
- STRO 230.90
- CARE N/A
- 52 Week Low
- STRO $1.67
- CARE $10.95
- 52 Week High
- STRO $6.13
- CARE $20.40
- Technical
- Relative Strength Index (RSI)
- STRO 29.77
- CARE 41.77
- Support Level
- STRO $1.80
- CARE $16.00
- Resistance Level
- STRO $2.15
- CARE $17.74
- Average True Range (ATR)
- STRO 0.13
- CARE 0.45
- MACD
- STRO 0.03
- CARE -0.07
- Stochastic Oscillator
- STRO 10.42
- CARE 52.82
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About CARE Carter Bankshares Inc.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. The Bank offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.